Mixed modeling and multiple imputation for unobservable genotype clusters

Statistics in Medicine

Volumn 27, Issue 15, 2008, Pages 2784-2801

  Foulkes, A S ^a   Yucel, R ^a   Reilly, M P ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antiretroviral therapy (ART); Dyslipidemia; Haplotype; Human immunodeficiency virus 1 (HIV 1); Mixed models; Multiple imputation

Indexed keywords

ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CELL ENZYME; ENDOTHELIAL LIPASE; LIVER TRIACYLGLYCEROL LIPASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ALLELE; ARTICLE; CHROMOSOME ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; FEMALE; GENE CLUSTER; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PREDICTION; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ANTI-RETROVIRAL AGENTS; DYSLIPIDEMIAS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; MODELS, STATISTICAL; OBSERVATION;

EID: 47249155352     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3051     Document Type: Article

References (62)

1. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-1320.
2. Schaid DJ. Evaluating associations of haplotypes with traits. Genetic Epidemiology 2004; 27(4):248-264.
3. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution 1995; 12:921-927.
4. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Human Heredity 2002; 53:79-91.
5. Schaid D, Rowland C, Tines D, Jacobson R, Poland G. Score tests for association between traits and haplotypes when linkage phase in ambiguous. American Journal of Human Genetics 2002; 70:425-434.
6. Zhao LP, Li SS, Khalid N. A method for the assessment of disease associations with single nucleotide polymorphism haplotypes and environmental variables in case-control studies. American Journal of Human Genetics 2003; 72:1231-1250.
7. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ. Estimation and testing of haplotype-environment interaction when linkage phase is ambiguous. Human Heredity 2003; 55:56-65.
8. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 2001; 68:978-989.
9. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. American Journal of Human Genetics 2006; 78(4):629-644.
10. Little RJA, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 1987.
11. Schafer JL. Multiple imputation: a primer. Statistical Methods in Medical Research 1999; 8:3-15.
12. Yucel R, Zaslavsky A. Imputation of binary treatment variables with measurement error in administrative data. Journal of the American Statistical Association 2005; 100(472):1123-1132.
13. Lin DY, Zeng D. Likelihood-based inference on haplotype effects in genetic association studies. Journal of the American Statistical Association 2006; 101(473):89-104.
14. Zhang H, Bonney G. Use of classification trees for association studies. Genetic Epidemiology 2000; 19:323-332.
15. Hoh J, Wille A, Zee R, Cheng S, Reynolds R, Lindpaintner K, Ott J. Selecting SNPs in two-stage analysis of disease association data: a model-free approach. Annals of Human Genetics 2000; 64:413-417.
16. Segal MR, Cummings MP, Hubbard AE. Relating amino acid sequence to phenotype: analysis of peptide-binding data. Biometrics 2001; 57:632-643.
17. Ritchie M, Hahn L, Roodi N, Bailey R, Dupont W, Pari F, Moore J. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. American Journal of Human Genetics 2001; 69:138-147.
18. Nelson M, Kardia S, Ferrell R, Sing C. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Research 2001; 11:458-470.
19. DiRienzo G, DeGruttola V. Nonparametric methods to predict HIV drug susceptibility phenotype from genotype. Statistics in Medicine 2003; 22(17):2785-2798.
20. Foulkes AS, DeGruttola V, Hertogs K. Combining genotype groups and recursive partitioning: an application to HIV-1 genetics data. Journal of the Royal Statistical Society, Series C 2004; 53(Part 2):311-323.
21. Schaid DJ, McDonnell K, Hebbring SJ, Cunningham JM, Thibodeau ST. Nonparametric tests of association of multiple genes with human disease. American Journal of Human Genetics 2005; 76:780-793.
22. Foulkes AS, Reilly M, Zhou L, Wolfe M, Rader DJ. Mixed modeling to characterize genotype-phenotype associations. Statistics in Medicine 2005; 24:775-789.
23. Becker T, Schumacher J, Cichon S, Baur M, Knapp M. Haplotype interaction analysis of unlinked regions. Genetic Epidemiology 2005; 29:313-322.
24. Little RJA, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 2002.
25. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-974.
26. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. AIDS 2003; 17:1179-1193.
27. Fontas E, van Leth F, Sabin CA, Friis-Moller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? Journal of Infectious Diseases 2004; 189:1056-1074.
28. Periard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, Marcovina SM, Glauser MP, Nicod P, Darioli R, Mooser V. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV cohort study. Circulation 1999; 100:700-705.
29. Hui DY. Effects of HIV protease inhibitor therapy on lipid metabolism. Progress in Lipid Research 2003; 42:81-92.
30. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine 2005; 352:48-62.
31. d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Moller N. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004; 18:1811-1187.
32. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2004; 17:2479-2486.
33. Hudson RR, Kaplan NL. The coalescent process and background selection. Philosophical Transactions of the Royal Society of London, Series B Biological Sciences 1995; 349:19-23.
34. Hudson RR. Linkage disequilibrium and recombination. In Handbook of Statistical Genetics, Balding D, Bishop M, Cannings C (eds). Wiley: New York, 2001; 309-324.
35. Hudson RR. Generating samples under a Wright-Fisher neutral model. Bioinformatics 2002; 18:337-338.
36. Nordbord M, Tavare S. Linkage disequilibrium: what history has to tell us. Trends in Genetics 2002; 18:83-90.
37. Donnelly P, Nordbord M, Joyce P. Likelihoods and simulation methods for a class of nonneutral population genetics models. Genetics 2001; 159:853-867.
38. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29:311-322.
39. Stephens M, Donnelly P. Inference in molecular population genetics. Journal of Royal Statistical Society, Series B 2000; 62:605-655.
40. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics 2003; 73:1162-1169.
41. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globin gene cluster. American Journal of Human Genetics 1984; 36:1239-1258.
42. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J, Salomaa V, Vartiainen E, Boerwinkle E, Sing CF. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nature Genetics 1998; 19:223-240.
43. McPeek MS, Strahs A. Assessment of linkage disequilibrium by the decay of haplotype sharing, with application to fine-scale genetic mapping. American Journal of Human Genetics 1999; 65:858-875.
44. Lien S, Szyda J, Schechinger B, Rappold G, Arnheim N. Evidence for heterogeneity in recombination in the human pseudoautosomal region: high resolution analysis by sperm typing and radiation-hybrid mapping. American Journal of Human Genetics 2000; 66:557-566.
45. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES. Linkage disequilibrium in the human genome. Nature 2001; 411:199-204.
46. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human genome. Science2002; 296:2225-2229.
47. Padhukasahasram B, Marjoram P, Nordborg M. Estimating the rate of gene conversion on human chromosome. American Journal of Human Genetics 2004; 75:386-397.
48. Demidenko E. Mixed Models: Theory and Applications. Wiley: New York, 2004.
49. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Wiley: New York, 2004.
50. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychological Methods 2002; 7(2):147-177.
51. Li K-H, Meng X-L, Raghunathan TE, Rubin DB. Significance levels from repeated p-values with multiply-imputed data. Statistica Sinica 1991; 1:65-92.
52. Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP. Associations among race/ethnicity, APOC-III genotypes and lipids in HIV-1 infected individuals on antiretroviral therapy. PLoS Medicine 2006; 3(3):e52.
53. Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein e polymorphism on apolipoprotein e, apolipoprotein b, and cholesterol metabolism. American Journal of Human Genetics 1988; 42(1):104-112.
54. Cohen JC, Vega GL, Grundy SM. Hepatic lipase: new insights from genetic and metabolic studies. Current Opinion in Lipidology 1999; 10:259-267.
55. Eichner JE, Dunn ST et al. Apolipoprotein e polymorphism and cardiovascular disease: a huge review. American Journal of Epidemiology 2002; 155(6):487-495.
56. Reilly MP, Foulkes AS, Wolfe M, Rader DJ. Higher-order lipase gene association with plasma triglycerides. Journal of Lipid Research 2005; 46(9):1914-1922.
57. DeLemos AS, Wolfe ML et al. Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol. Circulation 2002; 106(11):1321-1326.
58. Ma K, Cilingiroglu M et al. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proceedings of the National Academy of Sciences of the United States of America 2003; 100(5):2748-2753.
59. van Dijk KW, Rensen PC, Voshol PJ, Havekes LM. The role and mode of action of apolipoproteins ciii and av: synergistic actors in triglyceride metabolism? Current Opinion in Lipidology 2004; 15:239-246.
60. Mahley RW, Rall Jr SC. Apolipoprotein e: far more than a lipid transport protein. Annual Review of Genomics and Human Genetics 2000; 1:507-537.
61. Broedl UC, Jin W et al. Endothelial lipase: a modulator of lipoprotein metabolism upregulated by inflammation. Trends in Cardiovascular Medicine 2004; 14(5):202-206.
62. Westfall PH, Young SS. Resampling-based Multiple Testing. Wiley: New York, 1993.